Update on vaccine development in AIDS and cancer.
MacDougall
D S
DS
D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D000951:Antigens, Neoplasm / Q000276:immunology; D002272:Carcinoembryonic Antigen / Q000276:immunology / Q000627:therapeutic use; D005822:Genetic Vectors; D015497:HIV-1 / Q000235:genetics; D006292:Health Priorities; D006801:Humans; D007111:Immunity, Cellular; D016233:Immunotherapy, Active; D009077:Mucins / Q000276:immunology / Q000627:therapeutic use; D009154:Mutation; D009369:Neoplasms / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D009696:Nucleic Acids / Q000276:immunology / Q000627:therapeutic use; D010455:Peptides / Q000276:immunology / Q000627:therapeutic use; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014614:Vaccines, Synthetic
D016915:AIDS Vaccines; D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D009077:Mucins; D009696:Nucleic Acids; D010455:Peptides; D014614:Vaccines, Synthetic